Contrast agents for magnetic resonance imaging
Abstract
Contrast agent for imaging by magnetic resonance imaging comprising a chelating ligand and a metal ion transition, carrying said ligand a substituent which can react by chemical or biochemical pathway with a target substance causing a change of spin state, characterized it comprises: a) or formula (I) ** (See formula) ** in which: - R4 represents a hydrogen atom or an alkyl group of 1 to 4 carbon atoms, linear or branched, or a radical aryl; - W represents a group - (CH2) m-, m being equal to 0 or 1; - R5 represents a group capable of reacting with the target substance to cause a break between the N atom of the macrocycle and the carbon carrying said group R 5, or represents a hydrogen atom, provided that: i) when R5 represents a group can react with the target substance to cause a break between the N atom of the macrocycle and the carbon carrying said group R 5 (complexes Ia), substituents R1 to R3, designated by Ri, represent, independently of each other, an atom hydrogen or a group selected to adjust the solubility properties of dispersibility in biological media and of the magnetic moment of the complex, and can one of the Ri also represent a group can experience an electronic modification of the neighboring pyridyl group by reaction with the target substance ; ii) when R5 represents a hydrogen atom (Ib complex), one of the groups Ri represents a group can experience an electronic modification pyridyl group neighbor by reaction with the target substance, can represent the Ri groups remaining, independently of each other , a hydrogen atom or chosen to adjust the properties of solubility, dispersibility in biological media and of the magnetic moment of the complex; b) or formula (II) ** (See formula) ** in which: - R1 and R2, designated by Ri, represent, independently of one another, a hydrogen atom or a group chosen to adjust the properties of solubility, dispersibility in biological media and of magnetic moment of the complex; - R4 and W are as defined above; - R5 represents a (-C6X4-Y-R6), in which X is an electron withdrawing group, Y is a heteroatom selected from an oxygen atom, a nitrogen atom or a sulfur atom, and R6 represents a group capable of undergoing cleavage by a glycosidase, or an aminoacyl group capable of undergoing cleavage by an aminopeptidase, or susceptible acyl group undergoing cleavage by an esterase or a lipase, or a group capable of undergoing a retroaldol transformation by a natural aldolase , or a group capable of undergoing transformation by a phosphatase; - Z is a divalent group which forms with the two nitrogen atoms carrying as an aromatic cycle benzotriazole, triazole, tetrazole, pyrazole, aromatic ring may bear one substituent NO2.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
15 members in 8 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 0403389 | France | A | |
| 2005000784 | France | W |
Members15
| Document | Office | Kind | |
|---|---|---|---|
| FR2868320A1 | France | A1 | |
| WO2005094903A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2005094903A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1729818A2 | European Patent Office (EPO) | A2 | |
| US2007218010A1 | United States of America | A1 | |
| JP2007530646A | Japan | A | |
| FR2868320B1 | France | B1 | |
| EP1729818B1 | European Patent Office (EPO) | B1 | |
| AT443529TThis record | Austria | T | |
| ATE443529T1 | Austria | T1 | |
| DE602005016784D1 | Germany | D1 | |
| EP1729818B8 | European Patent Office (EPO) | B8 | |
| ES2334242T3 | Spain | T3 | |
| US8945514B2 | United States of America | B2 | |
| JP5704784B2 | Japan | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 5746947
Titles2
- German
- KONTRASTMITTEL FÜR DIE MAGNETRESONANZTOMOGRAPHIE
- English
- CONTRASTING AGENTS FOR MAGNETIC RESONANCE TOMOGRAPHY
Classification
- CPC, 4
- A61K49/106
- A61K49/085
- A61K49/10
- C07D401/14
- IPC, 5
- A61K49 00
- A61K49 06
- A61K49 10
- A61K49 12
- C07D401 14